Inventor · disambiguated record
Mark M. Menning
Also filed as: MENNING MARK · MENNING MARK M · MENNING MARK MICHAEL
13 granted patents·15 pending applications·132 citations·filing 2004–2023
92Inventor score
Files withGILEAD SCIENCES INC12DAHL TERRENCE C5BRISTOL-MYERS SQUIBB & GILEAD SCIENCES LLC3EIDOS THERAPEUTICS INC2MENNING MARK MICHAEL2
Top patents by PatentIndex Score
28 records- 0197US8716264B2Compositions and methods for combination antiviral therapyDAHL TERRENCE C·Filed 2008·Granted May 6, 2014·46 cites·38 claims
- 0297US8592397B2Compositions and methods for combination antiviral therapyDAHL TERRENCE C·Filed 2008·Granted Nov 26, 2013·42 cites·26 claims
- 0393US9457036B2Compositions and methods for combination antiviral therapyGILEAD SCIENCES INC·Filed 2014·Granted Oct 4, 2016·6 cites·16 claims
- 0489US8598185B2Unitary pharmaceutical dosage formDAHL TERRENCE C·Filed 2006·Granted Dec 3, 2013·12 cites·14 claims
- 0587US9018192B2Unitary pharmaceutical dosage formBRISTOL MYERS SQUIBB & GILEAD SCIENCES LLC·Filed 2013·Granted Apr 28, 2015·10 cites·2 claims
- 0686US9545414B2Unitary pharmaceutical dosage formBRISTOL-MYERS SQUIBB & GILEAD SCIENCES LLC·Filed 2015·Granted Jan 17, 2017·6 cites·19 claims
- 0784US11260047B2Formulations of AG10EIDOS THERAPEUTICS INC·Filed 2019·Granted Mar 1, 2022·4 cites·26 claims
- 0883US12005043B2Formulations of AG10EIDOS THERAPEUTICS INC·Filed 2022·Granted Jun 11, 2024·1 cites·26 claims
- 0982US8871271B2Method and composition for pharmaceutical productGILEAD SCIENCES INC·Filed 2013·Granted Oct 28, 2014·4 cites·9 claims
- 1077US9744181B2Compositions and methods for combination antiviral therapyGILEAD SCIENCES INC·Filed 2014·Granted Aug 29, 2017·0 cites·30 claims
- 1171US2017273994A1Compositions and Methods for Combination Antiviral TherapyGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 1266US2006246130A1Compositions and methods for combination antiviral therapyDAHL TERRENCE C·Filed 2004·Application pending·0 cites
- 1366US2017232019A1Compositions and Methods for Combination Antiviral TherapyGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 1466US2006234982A1Compositions and methods for combination antiviral therapyDAHL TERRENCE C·Filed 2004·Application pending·0 cites
- 1566US2014213556A1Compositions and methods for combination antiviral therapyGILEAD SCIENCES INC·Filed 2014·Application pending·0 cites
- 1661US2004224917A1Compositions and methods for combination antiviral therapyGILEAD SCIENCES INC·Filed 2004·Application pending·0 cites
- 1760US10039718B2Use of solid carrier particles to improve the processability of a pharmaceutical agentKOZIARA JOANNA M·Filed 2009·Granted Aug 7, 2018·1 cites·26 claims
- 1857US2014370102A1Method and composition for pharmaceutical productGILEAD SCIENCES INC·Filed 2014·Application pending·0 cites
- 1955US2004224916A1Compositions and methods for combination antiviral therapyGILEAD SCIENCES INC·Filed 2004·Application pending·0 cites
- 2055US2007077295A1Method and composition for pharmaceutical productGILEAD SCIENCES INC·Filed 2006·Application pending·0 cites
- 2155US2023330019A1Emulsion formulations of poorly water-soluble compoundsMENNING MARK MICHAEL·Filed 2023·Application pending·0 cites
- 2253US2017079999A1Unitary pharmaceutical dosage formBRISTOL-MYERS SQUIBB & GILEAD SCIENCES LLC·Filed 2016·Application pending·0 cites
- 2350US9688666B2Lamivudine saltsTOBIRA THERAPEUTICS INC·Filed 2014·Granted Jun 27, 2017·0 cites·12 claims
- 2445US2021046005A1Process for creating solid dispersionsMENNING MARK MICHAEL·Filed 2019·Application pending·0 cites
- 2542US10857102B2Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarateOLIYAI REZA·Filed 2011·Granted Dec 8, 2020·0 cites·5 claims
- 2642US2016081985A1Cenicriviroc compositions and methods of making and using the sameTOBIRA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2740US2010285122A1Tablets for combination therapyGILEAD SCIENCES INC·Filed 2010·Application pending·0 cites
- 2838US2015150810A1Tablets for combination therapyGILEAD SCIENCES INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark M. Menning files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →